A review on various analytical methods for determination of anthracyclines and their metabolites as anti–cancer chemotherapy drugs in different matrices over the last …
Y Pashaei, M Mehrabi, M Shekarchi - TrAC Trends in Analytical Chemistry, 2020 - Elsevier
Anthracyclines (ANT), belong to a group of antineoplastic drugs, are commonly used as
chemotherapeutic agents in the treatment of various cancers. During the past decade, the …
chemotherapeutic agents in the treatment of various cancers. During the past decade, the …
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
X Ying, HE Wen, WL Lu, J Du, J Guo, W Tian… - Journal of Controlled …, 2010 - Elsevier
Chemotherapy for brain glioma has been of limited value due to the inability of transport of
drug across the blood-brain barrier (BBB) and poor penetration of drug into the tumor. For …
drug across the blood-brain barrier (BBB) and poor penetration of drug into the tumor. For …
[HTML][HTML] Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum
CR Andrighetti-Fröhner, RV Antonio… - Memórias do Instituto …, 2003 - SciELO Brasil
Natural products are an inexhaustible source of compounds with promising pharmacological
activities including antiviral action. Violacein, the major pigment produced by …
activities including antiviral action. Violacein, the major pigment produced by …
Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations
G Liu, H Shen, J Mao, L Zhang, Z Jiang… - … applied materials & …, 2013 - ACS Publications
Transferrin (Tf), an iron-transporting serum glycoprotein that binds to receptors
overexpressed at the surface of glioma cells, was chosen as the ligand to develop Tf …
overexpressed at the surface of glioma cells, was chosen as the ligand to develop Tf …
The incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskers
Q Li, X Wang, X Lu, H Tian, H Jiang, G Lv, D Guo, C Wu… - Biomaterials, 2009 - Elsevier
Porous nanostructure with its unique properties is found to be able to hold promise in drug
delivery. We fabricated the one-dimensional titanium dioxide whiskers (TiO2 Ws) and …
delivery. We fabricated the one-dimensional titanium dioxide whiskers (TiO2 Ws) and …
Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles
Abstract Background Daunorubicin hydrochloride (DAUN· HCl), due to low oral
bioavailability poses the hindrance to be marketed as an oral formulation. Aim of the study …
bioavailability poses the hindrance to be marketed as an oral formulation. Aim of the study …
A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity
J Liu, Z Qiu, S Wang, L Zhou, S Zhang - Biomedical Materials, 2010 - iopscience.iop.org
The encapsulation of hydrophilic drug in polymeric nanoparticles with high loading remains
a challenge due to the rapid penetration of the drug to the external aqueous phase. In order …
a challenge due to the rapid penetration of the drug to the external aqueous phase. In order …
Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia
Background Daunorubicin is commonly used in the treatment of acute lymphoblastic
leukaemia (ALL). The aim of this study was to explore the kinetics of double strand break …
leukaemia (ALL). The aim of this study was to explore the kinetics of double strand break …
Synthesis of nanodiamond–daunorubicin conjugates to overcome multidrug chemoresistance in leukemia
Nanodiamonds (NDs) are promising candidates in nanomedicine, demonstrating significant
potential as gene/drug delivery platforms for cancer therapy. We have synthesized ND …
potential as gene/drug delivery platforms for cancer therapy. We have synthesized ND …
Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
Y Wang, M Fu, J Liu, Y Yang, Y Yu, J Li… - International journal …, 2019 - Taylor & Francis
Background: Chemotherapy for non-small-cell lung cancer (NSCLC) still leads to
unsatisfactory clinical prognosis because of poor active targeting and tumor metastasis …
unsatisfactory clinical prognosis because of poor active targeting and tumor metastasis …